Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-064610
Filing Date
2014-10-23
Accepted
2014-10-23 19:32:06
Documents
1
Period of Report
2014-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 15728
  Complete submission text file 0001209191-14-064610.txt   16964
Mailing Address
Business Address
SEIDENBERG BETH C (Reporting) CIK: 0001184592 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36548 | Film No.: 141170903

Mailing Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3260 BAYSHORE BOULEVARD BRISBANE CA 94005 415-287-2410
Atara Biotherapeutics, Inc. (Issuer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)